McKesson Corporation (MCK) has continued to attract investor attention with important movements within its corporate structure and impressive performance metrics. Despite a significant portion of MCK shares being sold by
Franklin Resources Inc. and an insider sell from chief HR officer Leann Smith, there were a series of acquisitions from other entities such as
Sanctuary Advisors LLC and
Wilmington Savings Fund Society FSB.
The company's stock has seen fluctuating performance, with strong trading days to underperforming periods compared to competitors. Important factors contributing to MCK's growth include its
Oncology focus and a series of strategic acquisitions, which led to raised price targets from prominent organizations like
Wells Fargo. A third quarter dip of 15.2% was noted, however, a bullish sentiment is observed from investor and television host
Jim Cramer, who frequently emphasized MCK as a buy.
Moreover, news of increased institutional ownership and endorsements from billionaires
Cliff Asness and
Ray Dalio cement MCK as a valuable stock. The company also announces quarterly dividends and has raised its full-year EPS guidance following a Q2 earnings beat. Amid these developments, McKesson Corporation announces the sale of
Rexall and
Well.ca Businesses to
Birch Hill Equity Partners.
Mckesson Corporation MCK News Analytics from Thu, 04 Jul 2024 07:00:00 GMT to Sat, 14 Dec 2024 18:02:34 GMT -
Rating 5
- Innovation 2
- Information 7
- Rumor 4
